Mulmit

BIOCRYST PHARMACEUTICALS INCBIOCRYST PHARMACEUTICALS INC

BCRX Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-31874,837,000340,989,000263,861,0001.21
2024-12-31450,712,000-2,543,000-88,881,000-0.43
2023-12-31331,412,000-103,709,000-226,539,000-1.18
2022-12-31270,827,000-148,435,000-247,116,000-1.33
2021-12-31157,170,000-177,720,000-184,062,000-1.03

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-31Stonehouse Jon P644
2026-08-31Milne Jill C.1,288
2026-08-31MILANO VINCENT1,159
2026-08-31McKee Amy E644
2026-08-31Frank Steven1,288
2026-06-11Milne Jill C.15,294
2026-06-11Milne Jill C.33,540
2026-06-11Galson Steven K15,294
2026-06-11Galson Steven K33,540
2026-06-11LEVIN ALAN G15,294
2026-06-11LEVIN ALAN G33,540
2026-06-11Frank Steven15,294

8-K events

FiledItems
2026-08-05Results of operations · Regulation FD disclosure · Financial statements and exhibits
2026-08-04Costs associated with exit or disposal activities
2026-06-29Costs associated with exit or disposal activities · Regulation FD disclosure · Financial statements and exhibits
2026-06-12Officer or director change · Submission of matters to a vote · Financial statements and exhibits
2026-05-06Results of operations · Regulation FD disclosure · Financial statements and exhibits
2026-05-04Regulation FD disclosure · Financial statements and exhibits
2026-02-26Results of operations · Regulation FD disclosure · Financial statements and exhibits
2026-01-23Officer or director change

Congressional trades (PTR)

MemberFiled
Hon. Gilbert Cisneros2026-09-04
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.